Acadia Healthcare Company, Inc. (ACHC) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The Healthcare name (Medical Care Facilities) last closed at $27.36. The rating moved from Strong Oversold to Oversold on August 18, 2026.

• Public ratingOversold (as of August 19, 2026)
• Last close$27.36
• Last changeMoved from Strong Oversold to Oversold on August 18, 2026
• SectorHealthcare
• IndustryMedical Care Facilities

See all oversold Healthcare stocks →

AI analysis

Acadia Healthcare shows the structural benefits of scale in behavioral-health delivery, with diversified inpatient and outpatient sites, recurring referral flows, and a playbook of accretive M&A. Revenue and cash flow profiles are relatively defensive, but margins and growth are sensitive to payer contracting and state-level regulatory outcomes. Near-term catalysts include quarterly results, payer negotiations, and any announced acquisitions; downside stems from reimbursement pressures, staffing cost inflation, and licensing or litigation shocks. Given limited social and filing-driven news in the immediate window, price action is likely to track fundamental updates and broader health-care sector flows.

Key factors

• Steady, defensive demand for behavioral-health services supports predictable utilization and revenue stability.
• Nationwide scale and diversified site mix (inpatient behavioral, outpatient clinics, residential programs) provide margin and referral advantages versus smaller providers.
• History and capability for M&A-driven growth and tuck-ins that can expand market share and improve unit economics.
• Outcomes- and quality-tracking investments support payer contracting and regulatory positioning.
• Macro environment is quiet in the near term, leaving stock moves more sensitive to company-specific earnings and payer developments.

Risks

• Payer reimbursement pressure and strategic MA plan pruning could compress rates or reduce admission volumes for certain payor mixes.
• Regulatory and licensing risk in multiple states, plus increased scrutiny of behavioral- and addiction-treatment providers.
• Labor and staffing shortages (nurses, therapists) can increase operating costs and constrain capacity expansion.
• Concentration risk in certain geographies or facility types could amplify localized reimbursement or regulatory impacts.
• Limited public social sentiment and near-term newsflow increases volatility around earnings or corporate actions.

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.